AQST – aquestive therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]
Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Form SC 13G/A Aquestive Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Form SC 13G Aquestive Therapeutics, Filed by: BlackRock, Inc.
Form 8-K Aquestive Therapeutics, For: Nov 01
Form 8-K Aquestive Therapeutics, For: Nov 06
Form 10-Q Aquestive Therapeutics, For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.